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Abstract: Cerebral ischemia and ischemic heart diseases, common entities nowadays, are the main manifestation of 
circulatory diseases. Cardiovascular diseases, followed by stroke, represent the leading cause of mortality worldwide. 
Both entities share risk factors, pathophisiology and etiologic aspects by means of a main common mechanism, 
atherosclerosis. However, each entity has its own particularities. Ischemic stroke shows a variety of pathogenic 
mechanisms not present in ischemic heart disease. An ischemic stroke increases the risk of suffering a coronary heart 
disease, and viceversa. The aim of this chapter is to review data on epidemiology, pathophisiology and risk factors for 
both entities, considering the differences and similarities that could be found in between them. We discuss traditional risk 
factors, obtained from epidemiological data, and also some novel ones, such as hyperhomocisteinemia or sleep apnea. We 
separate risk factors, as clasically, in two groups: nonmodifiables, which includes age, sex, or ethnicity, and modifiables, 
including hypertension, dyslipidemia or diabetis, in order to discuss the role of each factor in both ischemic events, 
ischemic stroke and coronary heart disease.  
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1. BACKGROUND 
  Ischemic heart disease and ischemic stroke are common 
entities that share in many cases a similar pathophysiology, 
based on arteriosclerosis. Usually, arteriosclerosis affects the 
patient widespread, so he becomes at risk for acute coronary 
syndrome (ACS) the same as for acute stroke. In both cases, 
a sudden change of circulation occurs, with resultant 
decreased blood supply to part of the heart or brain. Stroke, 
ocasionally, has been considered to be like a "heart attack" in 
the brain. Therefore it is clear that ACS and acute stroke 
share data on epidemiology, risk and etiological factors, and 
on therapeutic measures. Moreover, some studies have 
demonstrated that coronary artery disease is frequent among 
stroke patients, and also that chronic coronary artery disease 
also increases the risk of suffer a stroke [1-4]. 
  However, heart and brain are two different organs in their 
anatomy, physiology and location, with their own circulation 
peculiarities. This fact explains that we find differences in 
risk factors, some being more likely to lead to an ACS than 
to a stroke, and viceversa. There are also notable differences 
in the etiology, much more diverse in stroke than in the ACS, 
and, consequently, in treatment.  
  In this chapter we discuss the epidemiology and the risk 
factors for both diseases, analyzing their similarities and 
differences. 
2. EPIDEMIOLOGY OF CARDIOVASCULAR 
DISEASES 
  Cardiovascular system diseases represent the leading 
cause of death worldwide, although the mortality for this 
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cause is falling gradually due to advances in diagnosis and 
therapy. According to World Health Organization (WHO) 
data, in 2008, the mortality rate due to these diseases was 
214-455 deaths per 100,000, being lower in developed 
countries [5]. 
  If we look into the European Community, cardiovascular 
system diseases are also the leading cause of death in 
adulthood [6,7]. In 2005 the death rate from circulatory 
system diseases was 241.2 per 100,000 (295.4 in males, 196 
in females). This rate decreased to 226.1 (273 and 183, 
respectively) the following year [8]. 
  In Spain, there were 385,361 deaths in 2007. Analyzing 
the major groups of diseases, cardiovascular disease ranks 
first as cause of death in the year 2007, accounting for 32.2% 
of all deaths. For specific causes, ischemic heart diseases 
were the leading cause (37,222 deaths) and cerebrovascular 
disease the second (33,034 deaths) [9]. In Catalonia, also in 
2007, cardiovascular diseases were the second leading cause 
of death in men younger than 85 years (after the tumors) and 
the first in men older than that age; in women, there were the 
first cause after 75 years old [7]. 
  All these data give a clear idea of the extent and severity 
of these diseases. However, there are some differences in 
between the epidemiology of ischemic heart disease and 
cerebrovascular disease, which are outlined in the following 
paragraphs. 
2.1. Epidemiology of Ischemic Heart Disease  
  As discussed, coronary heart disease (CHD) is the 
leading cause of death in adulthood, accounting for 9.6% of 
deaths from specific causes. In Spain, in 2007, it was the 
leading cause of death among men (21.248, 10.6%) and the 
second leading cause of death among women (15.974, 8.7%) 
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caused 89.1 deaths per 100,000 in 2006 (123.2 in males, 62.4 
for females) [6]. 
  The incidence of myocardial infarction (MI) varies 
according to the study and it varies also according to the 
different age and sex groups. The WHO MONICA project, 
where data of 37 populations were collected during a 10-year 
period, showed mean incidence of CHD events of 434 per 
100.000 men-year [10]. Finland and United Kingdom 
(Belfast and Glasgow) had the highest rates (more than 700 
per 100.000) and the lowest were in China (81 per 100.000) 
and Catalonia (210 per 100.000). In the same project, annual 
rates were quite lower in women: mean incidence rate was 
103 events per 100.000 women-year. Incidence was higher 
in United Kingdom populations (188 and 265 per 100.000) 
and lower in China, Catalonia (35 per 100.000) and Toulouse 
(36 per 100.000).  
  Several epidemiological studies in the U.S. have placed 
the incidence between 200 and 300 cases per 100.000 [11-
17], being clearly higher in males (up to 486 cases per 
100.000). This gender difference, which is found in all 
studies, appears to be more evident in younger ages of life, 
while at older ages tends to equalize.  
  As discussed below, and unlike what happens with 
stroke, the incidence of ACS is highest in the 5th and 6th 
decade of life, to decrease later on [18].  
  The incidence of ACS follows a circadian rhythm, with a 
peak from 6:00 to noon when more than 1/3 of ACS occur, 
and a three-fold increase in the frequency of onset of MI at 
peak (9 am) as compared with trough (11 pm) periods 
[19,20]. In the study of Goldberg et al. [21], 23% of patients 
reported onset of symptoms within 1 hour after awakening.  
2.2. Epidemiology of Stroke 
  Cerebrovascular diseases are the second leading cause of 
death, also the second leading cause of dementia, and the 
leading cause of disability. By sex, they are the third leading 
cause of death in men, after ischemic heart disease and lung 
cancer, whereas in women they are the primary cause 
(18.964 female deaths from this cause in Spain in 2007, 
representing 10.2% of all deaths) [9]. In Catalonia, stroke 
causes 9.2% of overall mortality, 7.5% in males and 11.1% 
in women. The stroke mortality rates are clearly higher in 
non-industrialized countries [5].  
  The incidence of stroke varies widely depending on the 
study. The WHO places the global incidence of stroke at 
around 200 cases per 100.000 inhabitants [22], although data 
vary among countries. In a review of population-based 
studies since 1990, incidence varied from 130 to 410 cases 
per 100.000 person-years [23]. Highest rate was in Japan and 
lowest in United Kingdom, Germany and New Zealand. In 
the same review, the age-specific incidence of stroke 
increased progressively, and the range of stroke incidence in 
people aged 55 years or more was 420-650 per 100.000, 
except in Japan, Russia and Ukraine, where rates were 
higher. When difference by gender was analyzed, the 
incidence resulted higher in males in all studies. 
  Stroke, the same as myocardial infarction, also follows a 
circadian rhythm, and very similar to ischemic heart disease. 
To estimate the start time of the stroke is not easy, given that 
nearly a quarter of strokes occur during sleep [24]. Even 
taking this into account, a peak incidence has been observed 
between 6 am and 12 noon, when the 55% of ischemic 
strokes occur [25]. 
3. RISK FACTORS 
  An ischemic injury is a common mechanism for ischemic 
stroke (IS) and also for CHD. We find, logically, that many 
of the documented risk factors are present in both conditions, 
even if their contribution to the pathological event may be 
different. This fact is reviewed by Donnan et al. [26], who 
noted that identifiable risk factors explained 90% of CHD 
but only 60% of IS. Recently, an interesting paper has been 
published about this issue, in order to contrast risk factors 
pattern for each disease. It is a prospective cohort study 
conducted in Australia, on 2805 men and women, older than 
60, over a 16 year follow-up period, where the authors 
identify factors which predict similarly IS and CHD, while 
other factors predict only one of each condition [27].  
  It has to be noted that, since CHD and IS share many risk 
factors and aspects of pathophysiology, to suffer IS and/or 
CHD will involve a risk of a new ischemic event. In patients 
with a history of CHD, the risk of repeating a new ACS is 
much higher than the risk of IS; and in individuals with a 
history of IS, the risk of recurrent stroke is higher than the 
risk of ACS [27]. However, stroke is a major complication 
associated with high mortality in patients with CHD, 
especially when hypertension is also associated [28]. On the 
other hand, the risk of CHD in patients with a history of IS 
or TIA is moderately high [2]. A necropsy study of patients 
with fatal stroke found atherosclerotic plaques in the 
coronary arteries in 72.4% of patients, stenosis greater than 
50% in 37.5 % of them and myocardial infarction in 40.8% 
of the cases. These figures were roughly three times higher 
than what found in patients with other non-vascular 
neurological diseases [29]. 
  Pathophysiology of ischemic cardiopathy and stroke have 
some similarities but also some differences. Both share 
atherothrombosis as an etiological factor, but the frequency 
with which this is the major mechanism of ischemia varies in 
each case. Thus, rupture or erosion of vulnerable plaques in 
coronary arteries “causing” severe stenosis or occlusion are 
the commonest cause of MI [30,31], while coronary spasm, 
emboli or dissection are less frequent etiologies, accounting 
for only 5-15% of acute MI. A similar proportion of patients 
have angiographically normal coronary arteries [32-35]. In 
the case of stroke a wide variety of etiologies may be found. 
In fact, stroke is not a simple disease but the manifestation of 
several diseases with different pathophysiology. There are 
ischemic strokes and hemorrhagic strokes, whith a different 
mechanism while sharing some risk factors. In this article we 
will only refer to IS, which itself has a heterogeneous 
etiology and pathophysiology. 
  TOAST classification [36] defines 5 types: large artery 
disease (atherothrombotic), cardioembolism, small vessel 
disease, non-habitual and cryptogenic. Frequency of 
atherotrombotic stroke is only 15-48% (much less than in 
CHD), a cardioembolic source is found in 21-37% cases, 
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found in as many as the 38% cases [37-42]. Given this 
greater variety of etiologies risk factors for the different 
subtypes of stroke will also vary, with each risk factor 
playing a different role in each subtype of stroke considered. 
Hereafter, the importance of different risk factors for both 
ischemic heart disease and ischemic stroke will be discussed.  
  Vascular risk factors are usually divided into modifiable 
and non-modifiable. In this article we employ the same 
classification to review each factor, considering their role in 
cerebral and cardiovascular disease. These factors, together 
with a qualitative assessment of its influence in both 
patologies, based on its prevalence and its relevance, are 
summarized in Table 1. 
3.1. Non-Modifiable Risk Factors 
3.1.1. Age 
  Age is the strongest determinant of stroke, which is less 
common before 40 years old. According to data obtained 
from Framingham study, incidence of stroke increased 
steeply with age, becoming double in each successive decade 
from 55 years old on [43]. Hence, prevalence of stroke for 
individuals older than 80 years is approximately 27% 
compared with 13% for individuals 60-79 years of age [44]. 
The Framingham stroke risk profile (FSRP), developed 
decades ago, is still a useful tool to estimate, according to 
age, the specific 10 years probability of stroke by using 
clinical information, although conclusions should be drawn 
with caution. For instance, according to FSRP, the 10 years 
probability of stroke results 3% in a 60 years old man but 
9,7% in men older than 84, independently of other risk 
factors [45].  
  In the case of CHD, age is also, by far, one of the most 
powerful risk factors. The highest incidence of ACS is found 
in younger patients than stroke, around the 5
th and 6
th 
decades of life [18, 46]. Even though, a quarter of ACS 
patients are younger than 55 years, and a similar proportion 
are older than 75. An observational study conducted in Spain 
showed that 36% of patients were younger than 45 years old 
[46].  
Table 1.  Vascular Risk Factors: Relevance in Ischemic Cardiopathy and Ischemic Stroke 
 Ischemic  Cardiopathy  Ischemic  Stroke 
Non-modifiable:    
•  Age  +++ (50-70 y.)  +++ (older) 
•  Sex  ++ (male)  ++ (male) 
•  Ethnicity +  + 
•  Genetics-heredity ++  ++ 
•  Uncommon related factors  +  + 
Modifiable:    
•  High blood pressure  +++  +++ 
•  Diabetes +++  ++  (aterothrombotic-lacunar) 
•  Dyslipidemia +++  ++  (aterothrombotic-lacunar) 
•  Smoking +++  +++ 
•  Alcohol  + (dual relationship)  + (dual relationship) 
•  Obesity +++  ++ 
•  Physical inactivity  ++  ++ 
•  Diet ++  ++ 
•  Atrial fibrillation and other sources of embolism  +  ++ (cardioembolic) 
•  Other risk factors:     
 -Hyperhomocysteinemia  ++  ++ 
 -Hypercoagulability  +  + 
 -Lipoproteins  ++  + 
 -Inflammatory markers  +  + 
 -Obstructive sleep-apnea syndrome  ++  ++ 
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3.1.2. Sex 
  MI, the same as IS, is clearly more frequent among men. 
In Dubbo Study, male gender predicted similarly CHD and 
IS [27]. 
  A recent meta-analysis [47] showed that stroke is 33% 
more incident in men than in women. This fact is also 
observed in the FSRP, mentioned above. However, due to 
longer life expectancy and much higher incidence of stroke 
in older ages, women suffer more strokes than men [48]. 
Etiology and risk factors of stroke are not the same in men 
than in women: cardioembolism is the main cause of stroke 
in women, whereas large and small vessel disease is the main 
cause among men [49]. Women use to suffer stroke earlier 
than men and their risk factors’ profile is different [50]. 
Turtzo  et al. [51], when reviewing these different charac-
teristics, point that more women than men die from stroke 
and that, in women, there is a trend for increased stroke 
severity, for a recurrent stroke after 5 years, and for a poorer 
functional outcome after IS. 
  Regarding CHD, its prevalence is also higher among 
men.  The proportion of males rounds 64-71% in different 
series. This percentage increases in younger people and it 
tends to equalize when growing old [18, 52-54]. The most 
common found manifestation of CHD in women is angina 
pectoris, while in men is myocardial infarction [55]. 
3.1.3. Ethnicity 
  Stroke incidence is greater among black patients, 
approximately double than among white patients according 
to several studies. The study conducted in Manhattan by 
Sacco et al. [56] found that stroke incidence among black 
patients was 2.4 times that of white patients, and that among 
Hispanic patients it was 1.6 times that of white patients.  
  Different causes and mechanisms for stroke have been 
found to be more common in different race-ethnic groups, 
for example: hemorrhagic stroke –usually related to HBP- 
and young adults arteriopathy in Japan, extracranial athero-
sclerosis lesions in white patients vs. intracranial lesions in 
black, Hispanic and Asian patients. The reasons for that are 
still unclear. In the case of Africans an increased risk of 
ischemic stroke has been described related to sickle cell trait, 
but there is insufficient evidence to suggest an independent 
association [57]. 
  The same as stroke, ischemic heart diseases may differ 
across ethnics groups. In the case of Hispanics, they have 
excessive rates of diabetes, obesity, dyslipidemia and 
metabolic syndrome, being particularly vulnerable to heart 
failure [58].  South Asian immigrants in the United States 
also have a higher risk for CHD, compared to Caucasians, 
and a higher prevalence of modifiable risk factors like 
diabetes or dyslipidemia. Nevertheless, the presence of risk 
factors may not be the only explanation for a high risk of 
ischemic events in this population, and new factors as 
dysfunctional HDL have been reported to play a role [59]. 
3.1.4. Genetics-Heredity 
  Stroke incidence increases when there is a family history 
of stroke. The same occurs with CHD disease incidence, as 
observed in The Framingham Study: a family history of 
ischemic heart disease in first degree relatives younger than 
55 implies a relative risk of 1,5-1,7, independently to other 
risk factors [44]. These facts could be due to a familial 
association existing with other risk factors for the disease 
(cholesterol, hiperfibrinogenemia, HBP, diabetes…..), or due 
to independent factors, such as the controversially investi-
gated adrenergic receptor gene. Rexrode et al. [60] did not 
find association between the adrenergic receptor genetic 
variation studied and the risk of cardiovascular disease –MI 
or IS- in women. A recent study by Schurks et al. [61] sug-
gested that the Haplotype Gly16-Gln27-Thr164 polymor-
phism in the beta2-adrenergic receptor which had previously 
shown a protective effect on MI in men, is also associated 
with reduced risk of MI in Caucasian women, but not with 
an IS risk reduction.  
  Previously, an increased risk for both CHD and IS had 
been demonstrated in carriers of e4 allele for Apolipo-
proteine E. In young patients, several hereditary arterio-
pathies might be found to be the cause of ischemic stroke, 
such as CADASIL, CARASIL, Sneddon syndrome, mito-
condrial cytopathies, Fabry disease or different 
coagulopathies. All of them are rare in the case of stroke, and 
even rarer as a cause of CHD.  
3.1.5. Uncommon Related Factors 
  Many other factors have been said to affect the 
epidemiology of IS and/or CHD, although mechanisms are 
not well clarified and data are still lacking about it. Just to 
mention,  
  -Size: it has been said to be inversely associated with the 
long-term incidence of fatal stroke; in contrast, height is not 
significantly related with mortality due to CHD mortality 
[62]. 
  -Body fat distribution: it predicts long term stroke mor-
tality and also long term heart disease mortality in middle-
aged men [63]. 
  -Year station: a higher incidence of IS and of acute MI 
has been described related to changes –descent- in atmos-
pheric pressure [64] and during winter [65]. 
3.2. Modifiable Risk Factors 
  In this section we discuss modifiable, or treatable, risk 
factors for CHD and IS such as living habits, some 
atherogenic personal attributes (HBP, DM, DLP, obesity…) 
and certain diseases, which predispose to the occurrence of 
an ischemic event. Identified modifiable risk factors are 
responsible for 90% of myocardial infarction [66] while they 
explain only about 60% of strokes [26]. 
  These risk factors may have changed over the last years, 
as observed in the Lausanne Stroke Registry [67] where an 
increasing proportion of hypercholesterolemia but a 
decreasing proportion of high blood pressure, smoking habit 
and diabetes mellitus in patients were described over time. 
3.2.1. High Blood Pressure 
  High blood pressure (HBP) or hypertension affects nearly 
30% of the world’s population. It is a risk factor for stroke, 
CHD, chronic heart failure, kidney failure, vascular dementia 
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WHO data, 62% of all strokes and 49% of CHD are 
attributable to HBP. 
  The Framingham Heart Study [68] showed an increased 
relative risk (RR) of cardiovascular disease of 2, in patients 
with blood pressure 130-139/ 85-89 compared with patients 
with blood pressure lower than 120/80. The risk of CHD and 
stroke increases linearly when blood pressure is higher than 
115/75. Mortality due to IS and to MI also increases linearly 
and progressively when blood pressure is above 115/75, 
being double for every 20mm Hg systolic or 10mm Hg 
diastolic increase in blood pressure [69]. 
Blood Pressure and Stroke 
  HBP is the most important modifiable risk factor for a 
stroke of any type, ischemic or hemorrhagic, and also for 
transient ischemic attack. HBP accelerates the progression of 
atherosclerosis, one of the main predictors of ischemic 
stroke. In Framingham Study, most hypertension related 
strokes were due to atherothrombotic brain infarction. Thus, 
hypertension is a main risk factor not only for hemorraghic 
stroke but also, and at a similar extent, it is a main risk factor 
for IS [70]. Systolic, diastolic or both blood pressure values 
can contribute to the occurrence of stroke when they are 
high. In large-scale prospective cohort studies it has been 
observed that relative elevations of blood pressure, often 
undervalued by patient and doctors, may also increase the 
risk: 140-160/90-94 increases the risk of stroke by 1.5, 
>160/95 increases the risk by 3-4. Decreasing blood pres-
sure, even if modestly, may achieve 40% risk reduction of 
stroke, as described in prospective clinical assays [71,72].  
  When analyzing series of patients affected of ischemic 
stroke, HBP is found in 53-68% of patients [37-39]. The 
contribution of HBP to the occurrence of each different 
subtype of stroke is not the same, as reported in these series. 
In the Athens Stroke Registry [39], HBP is present in 80% of 
lacunar infarcts, in 73% of atherothrombotic, in 62% of 
cardioembolic, and in 62% of cryptogenic strokes. The 
Barcelona Stroke Registry [38] showed a predominant role 
of HBP in lacunar infarction, as well (76%).  
  A recent meta-analysis [73] showed the relation between 
higher diet salt intake and greater incidence of stroke (1.23 
relative risk). In the Dubbo study [27] HBP appears to be a 
stronger predictor of IS, compared to CHD.  
Blood Pressure and CHD 
  HBP is one of the main risk factors for CHD. According 
to the GRACE score, systolic blood pressure is the 
modifiable factor which better predicts acute myocardial 
infarction and related death [66]. Epidemiological data and 
other epidemiological studies have demonstrated that the 
incidence of cardiovascular diseases increases incrementally 
with blood pressure, even within the normal range (45% of 
cardiovascular events reported at Framingham study 
occurred at a systolic BP of 140 or lower). Although a 
threshold for the association between BP and cardiovascular 
risk is not well established, normal and high-normal BP 
conferred almost a 2-fold increased risk factor for cardio-
vascular disease, compared to optimal BP. These studies, as 
reviewed by Kannel et al. [70], also showed that the com-
bination of other risk factors such as metabolic syndrome 
greatly augments the hazard ratio of elevated blood pressure.  
  The study by Strazzullo et al. [73], already mentioned, 
shows a greater incidence of cardiovascular disease related 
to a higher salt intake (1.14 relative risk).  
3.2.2. Diabetes Mellitus 
  Diabetes mellitus (DM) is a disease with increasing 
prevalence [74]. It is associated with a high risk of both 
ischemic cardiopathy and cerebrovascular disease, for being 
a clearly predisposing factor for the development of both 
large-vessel and small-vessel atheroma. Diabetes patho-
physiological mechanisms to cause vascular disease are 
multiple [75]. It is estimated that 44-52% of deaths in 
diabetic patients are due to cardiovascular diseases [76]. 
Results are different depending on when the diagnosis of 
diabetes is established, before or after age 30. A study 
carried out in Wisconsin showed that, among patients with a 
younger onset of diabetes, ischemic cardiopathy and 
cerebrovascular disease caused 26.9% of deaths (the more 
frequent cause of death in this group is diabetes) while in 
patients with older onset this rate was 47.5% [77]. As 
discussed below, these deaths are mainly due to CHD. 
Diabetes Mellitus and CHD 
  DM is a key-factor in the occurrence of coronary 
syndrome. The prevalence of DM in ACS varies between 
21.1 and 31.7% among registries [52-54]. In the Honolulu 
Heart Program [78], a prospective cohort study which 
followed more than 7,000 men for 23 years, the age-adjusted 
rate of CHD was 14.1 per 1000 person-years in men with 
known diabetes, 8.8 in those with asymptomatic hypergli-
cemia and 5-5.9 in groups with normal glucose. This risk is 
not limited to men, as diabetic women have been also found 
to have an increased risk of CHD compared to men [55]. As 
noted earlier, ischemic heart disease is a major cause of 
death in diabetic individuals. In the study by Moss et al. 
[77], DM was the cause of death in 24.8% of people with 
younger onset DM and in 38% of individuals with older 
onset DM.  
Diabetes Mellitus and Stroke 
  DM is also a risk factor for the occurrence of ischemic 
stroke. In the Honolulu Heart Program, subjects with known 
diabetes and asymptomatic hyperglicemia showed an 
increased risk of ischemic stroke, and these associations 
were independent of age and other vascular risk factors [79]. 
Moreover, a recent study showed that in patients with a 
previous TIA or previous minor stroke, glucose intolerance 
increased the risk of stroke [80]. However, not all ischemic 
strokes are equally favoured by the DM: prevalence of DM 
is 18-32% in atherothrombotic infarction, 20-32% in lacunar 
infarction and somewhat less in cardioembolic one (8-21%), 
depending on the series [37-39,81].  
  In diabetic patients, cerebrovascular disease is a far less 
common cause of death than coronary heart disease. In the 
study by Moss et al. [77], cited previously, the stroke was 
the cause of death in 2.1 of younger onset diabetic patients 
and in 9.5 of the older onset group.  
 Epidemiology and Risk Factors of Cerebral Ischemia and Ischemic Heart Diseases  Current Cardiology Reviews, 2010, Vol. 6, No. 3    143 
3.2.3. Dyslipidemia 
  Hypercholesterolemia is a factor that has been 
demonstrated clearly related to atheromatosis [82]. Several 
studies demonstrate a direct relationship between cholesterol 
levels, triglyceride levels and cardiovascular mortality 
[83,84]. Even if dyslipidemia has been considered -and is 
still being considered- a risk factor for CHD and also for 
stroke, it may have a different relevance in each entity. At 
the moment no one discusses the relationship between high 
values of cholesterol and LDL-cholesterol, low levels of 
HDL-cholesterol and the presence of coronary atheroma and 
symptomatic coronary disease. However, the relationship 
between cholesterol and stroke appears to be more contro-
versial and inconsistent across studies, probably because 
stroke is a much more heterogeneous disease. Many series, 
especially the older ones, did not differ neither ischemic 
from hemorrhagic strokes in their analysis, nor the different 
types of ischemic stroke depending on etiology. Different 
data about the relationship between hypercholesterolemia 
and the two entities are exposed below.  
Dyslipidemia and CHD 
  The relationship established for dyslipidemia and the 
development of atheroma implies a close relationship with 
the development of CHD, as well. A high LDL and/or low 
HDL-cholesterol levels predict coronary events [27,85]. In 
the Asia Pacific Cohort Studies Collaboration (APCSC) 
study, each 1-mmol / l higher level of total cholesterol was 
associated with 35% increased risk of coronary death [86]. 
Different registers of CHD showed a proportion of patients 
with dyslipidemia of 45-54%, which is higher than the 
proportion of patients with diabetes [52-54].  
Dyslipidemia and Stroke  
  As discussed earlier, hypercholesterolemia has not been 
clearly established as a risk factor for stroke. There are some 
studies which found no significant relationship between 
cholesterol levels and incidence of stroke [87,88], even when 
analyzing hemorrhagic and ischemic stroke separately. By 
contrast, in the APCSC study each 1-mmol / l higher level of 
total cholesterol was associated with 25% increased risk of 
ischemic stroke (less than increased risk seen in the case of 
CHD, but still a significant risk), and with 20% decreased 
risk of fatal stroke hemorrhagic [86]. In the study by Simons 
et al. [27], unlike what observed with CHD, a high LDL-
cholesterol level predicted IS, but HDL- cholesterol level did 
not. This lack of consistency has been suggested to be due to 
the heterogeneity in the pathogenesis of ischemic stroke, thus 
some subtypes of stroke would be more related to hyper-
cholesterolemia [89]. This fact is reflected in prospective 
registries of stroke, where dyslipidemia is described in up to 
46% of atherothrombotic infarctions and up to 38% of 
lacunar infarctions, but in less than 20% of cardioembolic 
ones [37-39]. 
3.2.4 Smoking 
  Relationship in between smoking habit and athero-
sclerosis has been clearly established. Tobacco contributes to 
the progression of the atherosclerotic plaque and to its 
instability. It facilitates platelet aggregation, increases blood 
viscosity and damages the endothelium, among other 
mechanisms of action [90-94]. So, increased risk of CHD 
and IS occurs in smokers, as demonstrated, almost unani-
mously, in many studies.  
Smoking and CHD 
  Tobacco use is strongly associated with coronary disease. 
Studies have also shown that the risk increases with the 
number of cigarettes [95-97]. In a cohort of nearly 120.000 
female nurses, among smokers of more than 25 cigarettes per 
day, the relative risk of suffering from fatal CHD was 5.5 
[95]. In the Copenhagen City Heart Study, the risk increased 
2-3% for each gram of tobacco smoked daily [96]. In any 
case, even smokers of 1-4 cigarettes per day have increased 
risk of acute myocardial infartion [95]. Some studies 
conclude that the association of tobacco with CHD is higher 
in women than in men [96] and that this risk is also increased 
when smoking habit is associated with the use of oral 
contraceptives [98].  
  The attitude of quitting the habit is the best preventive 
measure, as ex-smokers can see their risk of CHD decrease 
over the years [95,96,99], reaching a risk similar to a non-
smoker person (someone who has never smoked) after about 
10 years.  
Smoking and Stroke 
  Smoking is an independent risk factor for all subtypes of 
ischemic stroke. A meta-analysis concluded that the relative 
risk of cerebral infarct associated with cigarette smoking was 
1.9 [100], with differences depending on age groups: RR in 
< 55 (before 55 years old) was 2.9, in age 55-74 was 1.8 and 
in patients older than 74, 1.1. As in CHD, risk was higher in 
women than in men and the risk was dose-dependent. In an 
epidemiologic study conducted in Minnesota, the relative 
risk resulted 3.6 in patients aged 50, 1.9 in patients aged 70 
and non-significant after 80 years old [101]. Risk of stroke 
was about twice as high for passive smokers than for non-
smokers [102,103].  
  Ex-smokers may reduce their risk of suffering a stroke 
till a RR of 1.2, although this RR remains higher in older 
people [100]. In the study conducted by Whisnant et al. 
[101], the increased risk was higher when comparing current 
smoker vs never & past smokers than when comparing 
people who ever smoked vs never non-smokers. 
3.2.5. Alcohol 
  Alcohol, taken in moderation, has proven to be a 
protective factor for cardiovascular disease, especially for 
CHD. Several hypotheses have been postulated to explain 
this fact, related to the effects of alcohol on lipid levels and 
platelet aggregation [104,105], to an effect on increased 
levels of estrogen [106], or even related to the assumption 
that moderate alcohol drinking is synonymous with social 
integration [107]. However, this beneficial effect only occurs 
for moderate alcohol intake, because, as discussed below, 
alcohol abuse is harmful and increases the risk of CHD, the 
same as stroke. 
Alcohol and CHD 
  Prospective studies have reported a lower risk of death 
from CHD among moderate drinkers, compared with 
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Denmark, men who drank daily a mean of 12 g of ethanol 
had the lowest risk to develope CHD [111], even less than 
men who drank less than once a day. In women, risk was 
also reduced if they drank at least one day a week, but no 
difference was found between drinking frequency.  
  However, it has to be remarked that binge drinking 
increases the risk of suffering CHD. In heavy drinkers, RR 
of death from cardiovascular disease was 2.05, most of them 
due to myocardial infarction [112]. Hence, adults’ risk of 
CHD in relation to volume of alcohol is described as a U-
shaped curve [110]. 
Alcohol and Stroke 
  As we have seen with ischemic heart disease, it seems to 
be a dual relationship between alcohol consumption and 
incidence of ischemic stroke. Moderate alcohol consumption 
is associated with lower incidence of ischemic stroke 
[113,114], but, on the other hand, heavy drinkers have a 
higher risk of stroke [115].
 It has been suggested that recent 
alcohol consumption may act as trigger [116].  
3.2.6. Obesity  
  Obesity is clearly associated to cardiovascular disease, IS 
and CHD. Firstly, a higher proportion of HBP, DM and 
dyslipidemia –three key factors related to cardiovascular 
risk- can be found among patients with obesity [117, 118]. 
Moreover, these patients use to have a more sedentary live 
and a less healthy diet than patients without obesity.  
  In a recent meta-analysis [119] the incidence of each co-
morbidity related to obesity and overweight has been 
estimated. Among these co-morbidities risk were estimated 
for CHD and stroke. For men, RR for CHD was 1.81 for 
obesity based on waist circumference (WC) and 1.72  for 
body mass index (BMC). Estimated RR for women were 
higher: 2.69 for obesity based on WC and 3.10 for BMI. 
Obesity also increases risk of stroke but RR was lower than 
for CHD. RR was 1.51 for males and 1.49 for females. The 
heterogenicity present in stroke phisiopathology may explain 
this risk, lower for IS than for CHD.  
  Taking into account that obesity is an increasing health 
problem, it is estimated that the prevalence of CHD will 
increase by a range of 5 to 16% due to this factor [120]. 
3.2.7. Physical Inactivity 
  Physical activity reduces risk of both CHD and IS. The 
reason for this beneficial effect is multifactorial. First, 
regular exercise lowers blood pressure and improves lipid 
profiles [121]. Physical activity also improves endothelial 
function [122,123]. Other possible mechanisms, such as the 
reduction of blood viscosity, fibrinogen levels, and platelet 
aggregability may contribute to the reduction of cardiac and 
cerebral ischemic events [124]. 
Physical Inactivity and CHD 
  Many studies have demonstrated that a sedentary life 
increases risk of CHD. A meta-analysis estimated a RR of 
death from CHD of 1.9 in people with sedentary occupations 
[125]. In a prospective study with post-menopausal women, 
both walking and vigorous exercise were associated with 
significant reduction in the incidence of CHD (closer to 
50%), irrespective of their age, race or body-mass index 
[126]. In patients with previous angina, regular exercise 
reduces the incidence of recurrences [127]. 
Physical Inactivity and Stroke 
  Similar to what is observed in ischemic heart disease, 
moderate and high levels of physical activity reduces the risk 
of IS. Compared to low-active individuals, moderately active 
individuals have a 20% lower risk and highly active indi-
viduals had a 27% lower risk of stroke incidence or mortality 
[124]. This decreased risk is related to both intensity and 
duration of activity [128]. 
3.2.8. Diet 
  Mediterranean diet is characterized by a high intake of 
monounsaturated fat, plant proteins, whole grains and fish, 
while a low consumption of red meat, refined grains, and 
sweets [129].  
  It is associated with beneficial effects on lipids, blood 
pressure and also inflammatory markers. Several studies 
have documented an inverse relationship between the 
adherence to the Mediterranean diet and the incidence of 
CHD and stroke.  
Diet and CHD  
  There are many studies, in many different populations, 
concluding that the Mediterranean diet is protective against 
the incidence of CHD. The Lyon Diet Heart Study, con-
ducted in patients with previous MI, showed that the Medi-
terranean diet prevents the incidence of both cardiovascular 
and, specifically, coronary events [130]. Similar results were 
found in the HALE project, a study conducted in several 
european countries, including elderly people (hazard ratio: 
0.61) [131]. CHD mortality was also reduced in elderly 
people with a greater adherence to Mediterranean diet 
(adjusted hazard ratio, 0.67). In a recent study including 
women aged 38-63, women with a higher adherence to 
Mediterranean diet had a lower incidence of CHD [132].  
Diet and Stroke  
  Only a few studies have specifically evaluated the effect 
of Mediterranean diet on the incidence of ischemic stroke. In 
the Nurses' Health Study, discussed earlier, women who 
adhered to the Mediterranean diet more closely had also a 
lower risk of IS [132]. In a previous study by Joshipura et al., 
it had been shown that the consumption of fruit and 
vegetables, basic part of the Mediterranean diet, significantly 
reduced the incidence of IS [133].  
3.2.9. Atrial Fibrillation and other Sources of Embolism 
  Cardioembolism is the second most common cause of 
ischemic stroke, accounting for 21-38% of ischemic strokes 
[37-39]. In contrast, coronary embolism is a rare cause of 
MI. Sequelae from a MI, as a ventricular segmental akinesia, 
ventricular aneurysm or ischemic cardiomyopathy may 
become an embolic source and therefore be the cause of 
cardioembolic brain infarction. 
  Atrial fibrillation (AF) is the most common cardiac 
source of embolic stroke, accounting for up to 50% of 
patients. This proportion increases with age. Other common 
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(30%), left ventricular thrombus, valve disease or prosthetic 
valves [134]. 
  Risk of ischemic stroke among patients with AF averages 
3-4% per year, but it varies widely depending on several 
factors [135,136]. In a sistematic review of the literature, 4 
consistent independent risk factors for stroke in patients with 
atrial fibrillation were found: prior stroke, increasing age, 
previous hypertension and previous diabetes. Prior stroke or 
TIA was the most powerful of these risk factors and confered 
a high stroke risk (average 10% per year) [135]. Age was 
also a consistent independent predictor of stroke in patients 
with AF, with an incremental increased risk of 1.5 per 
decade [135].  
  AF could also be considered a risk factor for CHD. In the 
Dubbo Study [27], AF predicted CHD, but it was a higher 
predictor for IS than for CHD. In fact, AF was, statistically, 
the most powerful predictive factor for IS.  
3.2.10. Other Risk Factors 
Hyperhomocysteinemia 
  It has been shown that homocysteine causes changes in 
the arterial wall, by different mechanisms, implying an 
increased risk of ACS and IS in subjects with hyperho-
mocysteinemia. This fact has been reflected in numerous 
studies.  
  In a meta-analysis performed by Ford et al. [137], each 
increase of 5 umol / l in homocysteine concentration 
corresponded to a non-significant OR for CHD of 1.06 for 2 
publications of cohort studies, 1.23 (95% CI 1.07-1.41) for 
nested case-controls studies and 1.70 (1.50-1.93) for case-
control studies. Similarly, the same trend is observed for 
cerebrovascular disease. The summary OR for a 5-umol / l 
increase in homocysteine concentration were 1.10 (0.94-
1.28) for cohort studies, 1.58 (1.35-1.85) for nested case-
control studies and 2.16 (1.65-2.82) for case-control studies. 
Hyperhomocysteinemia has been associated with both 
carotid and intracranial circulation disease, with a lower 
development of collateral circulation, and also with other 
risk factors directly related to CHD and to cerebrovascular 
disease, like hypertension [138].  
Hypercoagulopathy  
  Inherited thrombophilia such as deficiency of antithrom-
bin III, protein C or protein S, mutation of prothrombin gene 
G20210A or factor V Leiden have been associated to venous 
thrombosis, but their association with arterial disease 
remains controversial. Presence of an antiphospholipid anti-
body, such as lupic anticoagulant or anticardiolipin antibody 
may also lead to hypercoagulopathy. Different studies failed 
to find an etiological association between these factors and 
coronary disease or ischemic stroke, but some trials have 
suggested that thrombophilia should be important as an 
etiological factor in young subjects [139-141]. 
Lipoproteins  
  Lipoprotein (a) is an atherogenic lipoprotein which has 
been postulated as an independent risk factor for 
cardiovascular disease. Its plasma levels are not determined 
routinely. High levels of lipoprotein (a) have been correlated 
with both CHD [142] and IS [143], although their etiologic 
association is not clear. In the ARIC study, high levels of 
lipoprotein (a) significantly correlated with higher incidence 
of IS in blacks and white women, but not in white men 
[144]. ApoB/ApoA1 ratio also was associated with myo-
cardial infarction in the INTERHEART study [145]. In the 
Dubbo Study, both parameters were only predictors of an 
increased incidence of CHD, but not of IS [27].  
Inflammatory Markers  
  Since atherosclerosis is a chronic inflammatory process, 
several markers of chronic inflammation have been studied 
as potential cardiovascular risk factors. C-reactive protein 
level is a strong predictor of cardiovascular events, even 
more than LDL cholesterol [146], and for both CHD and IS 
[147-150]. Elevated leukocyte count is associated with 
coronary events, but in a recent prospective cohort study it 
was not associated with incidence of stroke [151].  
Obstructive Sleep-Apnea Syndrome (OSAS) 
  Many studies have shown that sleep disorders, especially 
OSAS, are associated with increased cardiovascular risk. 
Individuals with these disorders have 2-4 times greater risk 
of suffering an ischemic stroke [152]. A similar risk for both 
ACS and IS have been described in these patients [153]. 
Several pathophysiological mechanisms have been postu-
lated to explain this increased risk, such as the development 
of hemodynamic changes, atherosclerosis, arrhythmias, 
endothelial dysfunction and prothrombotic states, among 
others, all of them facilitated or triggered by hypoxemia and 
/ or apnea / snoring [152].  
4. SUMMARY 
  In summary, CHD and cerebrovascular disease share 
similar pathophysiological mechanisms and, consequently, 
many risk factors. However, the more complex etiology 
demonstrated for IS lead to a different incidence of these 
factors in each disease, CHD and IS, the same as in every 
stroke subtype.  
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